All Posts / ROYAL PEPTIDES RESEARCH

GHK-Cu vs AHK-Cu: One Amino Acid, Two Research Profiles

November 10, 20268 min readResearch Journal

A side-by-side look at the two most-discussed copper tripeptides: how their structures differ, what the published literature actually shows, and how to choose between them for a laboratory study.

Key takeaways

  • The only structural difference is the first amino acid. GHK-Cu starts with glycine; AHK-Cu starts with alanine, which adds a single methyl group.
  • GHK-Cu is naturally occurring and has been studied since it was isolated from human plasma in 1973. AHK-Cu is a synthetic analogue.
  • GHK-Cu has the far deeper literature, spanning fibroblast, extracellular matrix, wound-model and gene-expression research.
  • AHK-Cu's literature is narrow and centres on one 2007 ex vivo study of human hair follicles and dermal papilla cells.
  • Choose by model, not by hype: broad ECM or gene-expression work points to GHK-Cu; follicle and dermal papilla models are where AHK-Cu has published data.

What are copper tripeptides?

Copper tripeptides are short chains of three amino acids that bind a copper(II) ion. In both GHK-Cu and AHK-Cu, the histidine and lysine residues, together with the peptide backbone, form a tight binding pocket for copper. That shared histidyl-lysine motif is why the two molecules are so often discussed together.

Researchers are interested in this class because copper is a cofactor for enzymes involved in connective-tissue biology, such as lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase (antioxidant defence). A small peptide that carries copper in a controlled, chelated form is a useful tool for studying those pathways in cell and tissue models.

Naturally occurring

GHK-Cu

Gly – His – Lys · Cu²⁺

Glycyl-L-histidyl-L-lysine copper(II). INCI name: Copper Tripeptide-1.

Synthetic analogue

AHK-Cu

Ala – His – Lys · Cu²⁺

L-alanyl-L-histidyl-L-lysine copper(II). INCI name: Copper Tripeptide-3.

GHK-Cu explained

GHK was isolated from human plasma albumin in 1973 by Loren Pickart. It occurs naturally in plasma, saliva and urine and has a very high affinity for copper(II), high enough to take copper from the transport site on albumin. Published measurements put plasma GHK at about 200 ng/mL at age 20, falling to around 80 ng/mL by age 60, which is part of why it attracts interest in ageing research.1,4

What the GHK-Cu literature covers

  • Fibroblasts and extracellular matrix. In cultured fibroblasts, GHK-Cu stimulated collagen synthesis at very low (picomolar to nanomolar) concentrations. Later work reported increased collagen and elastin production in human dermal fibroblasts and effects on matrix metalloproteinases (MMP-1, MMP-2) and their inhibitor TIMP-1.1,2
  • Gene expression. Analyses of Broad Institute Connectivity Map data reported that GHK altered expression of roughly 31% of human genes by 50% or more, with more genes up-regulated than suppressed.1
  • Antioxidant activity. Reviews describe GHK-Cu effects on antioxidant enzymes and its ability to quench certain reactive species in cell models.3,4
  • Animal wound models. A long series of rodent and rabbit studies examined wound contraction, granulation tissue and angiogenesis.1
Context matters. Much of the GHK-Cu literature comes from the research group that discovered it, and many findings are from cell culture or animal models. Treat gene-expression data as hypothesis-generating rather than proof of a functional outcome.

AHK-Cu explained

AHK-Cu swaps GHK's glycine for alanine. It is a synthetic analogue rather than a naturally identified plasma peptide, and it is best known in cosmetic-ingredient catalogues as Copper Tripeptide-3.

What the AHK-Cu literature covers

The key primary study is Pyo et al. (2007), published in Archives of Pharmacal Research. Working with human hair follicles in organ culture and cultured dermal papilla cells (DPCs), the authors reported that:5

  • AHK-Cu at 10⁻¹² to 10⁻⁹ M stimulated elongation of human hair follicles ex vivo and proliferation of DPCs in vitro.
  • At 10⁻⁹ M, the Bcl-2/Bax ratio rose and cleaved caspase-3 and PARP fell, pointing to anti-apoptotic signalling. The reduction in apoptotic cells counted by flow cytometry was not statistically significant.
Watch the dose. Supplier technical data summarising this work notes that follicle length increased at 0.001–1 nM but decreased at 10–100 nM. A biphasic response like this is a strong reason to run a full concentration series rather than a single dose.6

GHK-Cu vs AHK-Cu: side-by-side comparison

PropertyGHK-CuAHK-Cu
SequenceGly-His-Lys + Cu²⁺Ala-His-Lys + Cu²⁺
First residueGlycine (side chain: H)Alanine (side chain: CH₃)
OriginNaturally occurring (human plasma, 1973)Synthetic analogue
INCI nameCopper Tripeptide-1Copper Tripeptide-3
Formula (Cu complex)C₁₄H₂₂CuN₆O₄C₁₅H₂₄CuN₆O₄
Approx. molecular weight~402 g/mol~416 g/mol
Depth of literatureExtensive: decades of in vitro, animal and gene-expression workLimited: centred on one 2007 ex vivo/in vitro study
Main models studiedDermal fibroblasts, ECM remodelling, wound models, gene-expression profiling, antioxidant assaysHuman hair follicle organ culture, dermal papilla cells
Reported active rangePicomolar to nanomolar in fibroblast collagen assays10⁻¹²–10⁻⁹ M in follicle and DPC assays; inhibitory at higher nM

Molecular weights refer to the neutral copper complex. Salt forms (acetate, HCl) weigh more, so always calculate concentrations from the exact form on your certificate of analysis.

How deep is the evidence?

This is the most important difference, and it is often glossed over. GHK-Cu has been the subject of research for roughly five decades, including multiple peer-reviewed reviews, mechanistic cell studies and animal models. AHK-Cu, by contrast, rests on a very small primary literature. Independent reviewers have pointed out that the AHK-Cu-specific record is essentially a single 2007 study that has not been independently replicated.7

That does not make AHK-Cu uninteresting. It makes it an open research question: there is room for replication studies, head-to-head comparisons with GHK-Cu in the same follicle model, and dose-response work that maps the biphasic effect more precisely.

Choosing one for your study

Lean towards GHK-Cu if you are studying

  • Fibroblast behaviour, collagen and elastin synthesis, or ECM remodelling
  • Gene-expression or pathway-level responses to a copper peptide
  • Antioxidant or inflammatory signalling in cell models
  • Work where you need a large body of prior data to benchmark against

Consider AHK-Cu if you are studying

  • Dermal papilla cell proliferation or survival signalling
  • Hair follicle organ-culture models
  • Structure-activity questions: how one residue change alters a copper tripeptide's activity

Design tips for a head-to-head study

  • Run both peptides in the same model, at matched molar concentrations, across a wide range (for example 10⁻¹² to 10⁻⁷ M).
  • Include copper and peptide controls: the copper-free tripeptide and an equimolar copper salt help separate peptide effects from copper effects.
  • Correct for salt form and net peptide content from each batch's COA before preparing stock solutions.

Handling, storage and quality

Copper tripeptides are supplied as lyophilised powders with the characteristic blue colour of the copper complex. For laboratory handling:

  • Store sealed, lyophilised material at −20 °C or below, protected from light and moisture.
  • Let vials reach room temperature before opening to avoid condensation.
  • Prepare aliquots to limit freeze–thaw cycles.
  • A colour shift away from blue can indicate copper loss or degradation; check identity before use.

When comparing suppliers, look for batch-specific identity (mass spec) and purity (HPLC) data. Our 12-point vendor checklist and guide to research-grade vs pharmaceutical-grade peptides explain what to look for.

Copper peptides at Royal Peptides

Source both for a side-by-side study

Our GHK-Cu batches are third-party tested with lot-specific COAs in our COA library. Kits ship from a single lot, so every vial in a study matches.

GHK-Cu copper peptide research vial

50 mg & 100 mg

GHK-Cu Copper Peptide

From $55.25$65.00

Shop GHK-Cu →
GHK-Cu 100 mg 10-vial research kit

10-vial kit · one lot

GHK-Cu 100 mg × 10 vials

$408.00$480.00

Shop the kit →
AHK-Cu copper tripeptide research powder

Copper Tripeptide-3

AHK-Cu Peptide Powder

$29.75$35.00

Shop AHK-Cu →

Frequently asked questions

What is the difference between GHK-Cu and AHK-Cu?

Both are copper(II) complexes of a three-amino-acid peptide ending in histidine-lysine. GHK-Cu begins with glycine and occurs naturally in human plasma; AHK-Cu begins with alanine and is synthetic. GHK-Cu has a much larger research literature, while AHK-Cu research has focused mainly on hair follicle and dermal papilla cell models.

Is AHK-Cu stronger than GHK-Cu?

There is no head-to-head published study that establishes one as stronger. The two have mostly been tested in different models, so their results cannot be compared directly. A matched-concentration study in the same model would be needed to answer this.

Why is AHK-Cu linked to hair follicle research?

Its best-known study (Pyo et al., 2007) used human hair follicles in organ culture and cultured dermal papilla cells, reporting follicle elongation and DPC proliferation at picomolar to nanomolar concentrations. That single study defines most of what is known about AHK-Cu specifically.

What are the INCI names of GHK-Cu and AHK-Cu?

GHK-Cu is listed as Copper Tripeptide-1. AHK-Cu is listed as Copper Tripeptide-3.

How should copper peptides be stored?

Keep sealed lyophilised powder at −20 °C or below, protected from light and moisture. Bring vials to room temperature before opening and aliquot to avoid repeated freeze–thaw cycles.

Are GHK-Cu and AHK-Cu approved for human use?

No. The products sold by Royal Peptides are supplied strictly for in-vitro laboratory research. They are not drugs, supplements, food or cosmetics and are not for human or veterinary use. See Research Use Only explained.

References

  1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMC6073405
  2. Maquart FX, Pickart L, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988.
  3. Pickart L, Vasquez-Soltero JM, Margolina A. GHK-Cu may Prevent Oxidative Stress in Skin by Regulating Copper and Modifying Expression of Numerous Antioxidant Genes. Cosmetics. 2015;2(3):236. MDPI
  4. The potential of GHK as an anti-aging peptide. 2020. PMC8789089
  5. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834–839. Record
  6. Cayman Chemical. Copper Tripeptide-3 (hydrochloride), product information. caymanchem.com
  7. Outliyr. AHK-Cu (Copper Tripeptide) evidence report. outliyr.com

For in-vitro laboratory research use only. Not for human or veterinary use. Royal Peptides products are not drugs, supplements, food or cosmetics and have not been evaluated or approved by the FDA or any regulator. This article summarises published research for educational purposes and is not medical advice.

ROYAL PEPTIDES · RESEARCH & INSIGHTS